Retrospective analysis reveals increasing bladder carcinoma cases in youth, highlighting schistosomiasis connections.
Background: Carcinomas, erstwhile considered diseases of advancing age, are increasingly being observed in the young, requiring comprehensive evaluation and specialised care to ensure the best possible outcomes. Objective: This study aimed to evaluate the pattern and trend of bladder carcinoma in the young in northern Nigeria. Materials and Methods: This was a retrospective Cancer Registry-based study in Aminu Kano Teaching Hospital, Kano, Nigeria, and included all bladder carcinomas diagnosed from 2012 to 2022. Results: In the 11 years studied, 338 bladder carcinomas were diagnosed, with a mean age of 54.3 years and the male-to-female ratio of 7:1. Overall, the proportion of cases <40 years of age was 19.8% (range: 8.6%–31.6%). The predominant histological subtype was transitional cell carcinomas at 59.8% (202/338 cases), followed by squamous cell carcinoma at 36.7% (124/338) and adenocarcinomas at 12 (3.6%). Schistosomiasis comorbidity with carcinoma of the bladder was more frequent among those <40 years (16% vs. 7%; P = 0.02). With P = 0.03, there was a statistically significant difference in comorbidity with the parasite in those <40 years and ≥40 years. Conclusion: Bladder cancer in <40 years is strongly associated with schistosomiasis and about 1 out of every 5 bladder carcinomas occur in patients <40 years of age. With a high frequency of schistosomiasis and reviewed literature indicating high exposure to polycyclic aromatic amines and high incidence of urinary tract infections, there is a need to institute healthcare policies that will nip the menace of the disease in the bud.
No takes yet. Share an insight, caveat, or question.
Jimoh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: